BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 19811323)

  • 1. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation.
    Zhou F
    Int Rev Immunol; 2009; 28(3-4):239-60. PubMed ID: 19811323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of viral immune evasion proteins to inhibit MHC class I antigen processing and presentation.
    Zhou F
    Int Rev Immunol; 2009; 28(5):376-93. PubMed ID: 19811316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
    Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
    BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.
    Canaday DH; Ziebold C; Noss EH; Chervenak KA; Harding CV; Boom WH
    J Immunol; 1999 Jan; 162(1):372-9. PubMed ID: 9886409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes.
    Lee YJ; Benveniste EN
    J Immunol; 1996 Aug; 157(4):1559-68. PubMed ID: 8759739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages.
    Delvig AA; Lee JJ; Chrzanowska-Lightowlers ZM; Robinson JH
    J Leukoc Biol; 2002 Jul; 72(1):163-6. PubMed ID: 12101276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.
    Bovolenta C; Lorini AL; Mantelli B; Camorali L; Novelli F; Biswas P; Poli G
    J Immunol; 1999 Jan; 162(1):323-30. PubMed ID: 9886402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes.
    Zhou F; Chen J; Zhao KN
    J Gen Virol; 2013 Nov; 94(Pt 11):2504-2514. PubMed ID: 23956301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxoplasma gondii glycosylphosphatidylinositols up-regulate major histocompatibility complex (MHC) molecule expression on primary murine macrophages.
    Debierre-Grockiego F; Molitor N; Schwarz RT; Lüder CG
    Innate Immun; 2009 Feb; 15(1):25-32. PubMed ID: 19201822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of major histocompatibility complex antigens in squamous cell carcinomas of the head and neck: effects of interferon gene transfer.
    Arosarena OA; Baranwal S; Strome S; Wolf GT; Krauss JC; Bradford CR; Carey TE
    Otolaryngol Head Neck Surg; 1999 May; 120(5):665-71. PubMed ID: 10229590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma mediates antigen trafficking to MHC class II-positive late endosomes of enterocytes.
    Büning J; Schmitz M; Repenning B; Ludwig D; Schmidt MA; Strobel S; Zimmer KP
    Eur J Immunol; 2005 Mar; 35(3):831-42. PubMed ID: 15688349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
    Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
    Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha.
    Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U
    Eur J Immunol; 2001 May; 31(5):1475-84. PubMed ID: 11465104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The direct effect of IL-12 on tumor cells: IL-12 acts directly on tumor cells to activate NF-kappaB and enhance IFN-gamma-mediated STAT1 phosphorylation.
    Su W; Ito T; Oyama T; Kitagawa T; Yamori T; Fujiwara H; Matsuda H
    Biochem Biophys Res Commun; 2001 Jan; 280(2):503-12. PubMed ID: 11162546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells.
    Leeuwenberg JF; Van Damme J; Meager T; Jeunhomme TM; Buurman WA
    Eur J Immunol; 1988 Sep; 18(9):1469-72. PubMed ID: 3139431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by woodchuck hepatitis virus of class I major histocompatibility complex presentation on hepatocytes is mediated by virus envelope pre-S2 protein and can be reversed by treatment with gamma interferon.
    Wang J; Michalak TI
    J Virol; 2006 Sep; 80(17):8541-53. PubMed ID: 16912304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and expression analysis of interferon-gamma-inducible-lysosomal thiol reductase gene in large yellow croaker (Pseudosciaena crocea).
    Zheng W; Chen X
    Mol Immunol; 2006 May; 43(13):2135-41. PubMed ID: 16478632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.